Antisense Strategies
Journal:
Current Molecular Medicine
Volume:
4
Page:
465-487
Author(s):
Stanley T. Crooke
Small Molecule Toxins Targeting Tumor Receptors
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2311-2334
Author(s):
Marcin Dyba, Nadya I. Tarasova and Christopher J. Michejda
Effects of Specific Cyclooxygenase-2 Inhibitors on Carcinogenesis
Journal:
Medicinal Chemistry Reviews - Online (Discontinued)
Volume:
1
Page:
291-295
Author(s):
John W. Ho, Jing Zheng Song and Qian Li
Leukotriene A4 Hydrolase as a Target for Cancer Prevention and Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
267-283
Author(s):
X. Chen, S. Wang, N. Wu and C. S. Yang
Drug Delivery Systems for Brain Tumor Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1341-1353
Author(s):
Jarkko Rautioa and Prashant J. Chikhale
The Pharmacological Treatment of Cachexia
Journal:
Current Drug Targets
Volume:
5
Page:
265-277
Author(s):
Josep M. Argiles, Vanessa Almendro, Sílvia Busquets and Francisco J. Lopez-Soriano
Farnesylated Proteins as Anticancer Drug Targets: From Laboratory to the Clinic
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
123-138
Author(s):
Patrizia Russo, Maura Loprevite, Alfredo Cesario and Andrea Ardizzoni
Angiogenesis: A Target for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
11-26
Author(s):
Giampaolo Tortora, Davide Melisi and Fortunato Ciardiello
Death Receptor Ligands: New Strategies for Combined Treatment with Ionizing Radiation
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
334-342
Author(s):
Patrizia Marini and Claus Belka
Sch-66336 (Sarasar®) and Other Benzocycloheptapyridyl Farnesyl Protein Transferase Inhibitors: Discovery, Biology and Clinical Observations
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
1103-1114
Author(s):
Arthur G. Taveras, Paul Kirschmeier and Charles M. Baum